Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19
The stock gave multibagger returns of 160 per cent in just 1 year whereas BSE Sensex Index is up by 5 per cent.
On Wednesday, one of the Top Gainers on BSE, shares of Wockhardt Ltd were locked in a 5 per cent upper circuit to Rs 1,421.60 per share from its previous closing of Rs 1,353.95 per share. The stock’s 52-week high is Rs 1,678.60 per share while its 52-week low is Rs 489.20 per share.
Wockhardt operates as a global pharmaceutical and biotechnology entity, specializing in the production of diverse pharmaceutical products including finished dosage formulations, injectables, biopharmaceuticals, and topical treatments. Notably, Wockhardt holds a significant market position, ranking among the top three Indian generic companies in the UK and securing the sixth-largest generic supplier status within the retail and hospital sectors of Ireland. Furthermore, it boasts the distinction of having the number one Methycobalamin brand in India, highlighting its strong presence and market leadership in key therapeutic areas.
DSIJ's DSIJ's ‘Mid Bridge’ service recommends well researched Mid-Cap stocks for smart investing. If this interests you, do download the service details here.
The company has a market cap of over Rs 23,000 crore and as of December 2024, Rakesh Jhunjhunwala’s portfolio owns 28,37,005 shares or a 1.75 per cent stake in the company (now his portfolio is owned by his Rekha Rakesh Jhunjhunwala since December 2020). In just 1 day, Jhunjhunwala’s portfolio gained Rs 19,19,23,388.25 (28,37,005 shares x Rs 67.65 per share gain today).
The stock gave multibagger returns of 160 per cent in just 1 year whereas BSE Sensex Index is up by 5 per cent. Investors should keep an eye on these Small-Cap pharma stocks.
Disclaimer: The article is for informational purposes only and not investment advice.